The stock of Purple Biotech Ltd ADR (PPBT) has gone down by -42.36% for the week, with a -43.15% drop in the past month and a -38.09% drop in the past quarter. The volatility ratio for the week is 32.44%, and the volatility levels for the past 30 days are 14.93% for PPBT. The simple moving average for the past 20 days is -38.21% for PPBT’s stock, with a -58.51% simple moving average for the past 200 days.
Is It Worth Investing in Purple Biotech Ltd ADR (NASDAQ: PPBT) Right Now?
Additionally, the 36-month beta value for PPBT is 0.98. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for PPBT is 25.80M and currently, short sellers hold a 0.86% ratio of that float. The average trading volume of PPBT on April 17, 2024 was 97.03K shares.
PPBT) stock’s latest price update
The stock of Purple Biotech Ltd ADR (NASDAQ: PPBT) has decreased by -29.36 when compared to last closing price of 0.58.Despite this, the company has seen a loss of -42.36% in its stock price over the last five trading days. Zacks Investment Research reported 2024-03-13 that Purple Biotech Ltd. Sponsored ADR (PPBT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately.
PPBT Trading at -43.10% from the 50-Day Moving Average
After a stumble in the market that brought PPBT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.92% of loss for the given period.
Volatility was left at 14.93%, however, over the last 30 days, the volatility rate increased by 32.44%, as shares sank -41.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.55% lower at present.
During the last 5 trading sessions, PPBT fell by -42.36%, which changed the moving average for the period of 200-days by -70.14% in comparison to the 20-day moving average, which settled at $0.6521. In addition, Purple Biotech Ltd ADR saw -47.17% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for PPBT
The total capital return value is set at -0.32. Equity return is now at value -49.02, with -40.19 for asset returns.
Based on Purple Biotech Ltd ADR (PPBT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -56.58. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -5.47.
Currently, EBITDA for the company is -22.07 million with net debt to EBITDA at 0.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.20.
Conclusion
In conclusion, Purple Biotech Ltd ADR (PPBT) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
